Robert M. Wachter, MD; Michael D. Howell, MD, MPH
JAMA. 2018;320(1):25-26. doi:10.1001/jama.2018.5605
In this Viewpoint, Robert Wachter and Michael Howell from Google discuss the prospects that medicine is finally poised to realize improvements in quality, safety, and productivity from investments in health information technology and digitization, and from growing competencies in systems thinking and population health
Nilay D. Shah, PhD; Ewout W. Steyerberg, PhD; David M. Kent, MD, MS
JAMA. 2018;320(1):27-28. doi:10.1001/jama.2018.5602
This Viewpoint describes 4 major barriers to useful risk prediction that may not be easily overcome by new methods in machine learning and, in some instances, may be more difficult to overcome in the era of big data.
Ron Daniels, JD, LLM; Victor Dzau, MD
JAMA. 2018;320(1):29-30. doi:10.1001/jama.2018.7902
This Viewpoint summarizes a 2018 National Academies of Sciences, Engineering, and Medicine (NASEM) report that details challenges to support of biomedical scientists in the United States and proposes solutions, including public-private partnerships and a dedicated line of Congressional funding to support next-generation researchers and innovation.
Matthew E. Hirschtritt, MD, MPH; Penny M. Heaton, MD; Thomas R. Insel, MD
free access
JAMA. 2018;320(1):31-32. doi:10.1001/jama.2018.4478
In this Viewpoint, Insel and colleagues discuss the roles that private sector companies and foundations might play and the advantages of public-private partnerships in nurturing new and early-career physician-investigators given an always-challenging funding environment and ever-increasing hurdles young physicians must overcome to establish a research career.